KBIO

KaloBios Pharmaceuticals, Inc. News Headlines

$1.81
*  
0.02
1.12%
Get KBIO Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading KBIO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Cerulean Pharma (CERU) Worth Watching: Stock Soars 30.6% - Tale of the Tape
8/14/2014 9:25:00 AM - Zacks.com


KaloBios (KBIO) Enters Oversold Territory - Tale of the Tape
8/13/2014 10:04:34 AM - Zacks.com


Relypsa (RLYP) Worth Watching: Stock Gains 13.3% - Tale of the Tape
8/11/2014 9:46:00 AM - Zacks.com


KaloBios Regains Global Rights To KB001-A, Ends Deal With Sanofi Pasteur
7/28/2014 10:50:00 PM - RTT News


KaloBios Regains Global Rights To KB001-A From Sanofi Pasteur
7/28/2014 7:04:00 PM - RTT News


Akorn (AKRX) in Focus: Stock Moves 5.9% Higher - Tale of the Tape
6/23/2014 9:18:00 AM - Zacks.com


Aquinox Pharmaceuticals (AQXP) in Focus: Stock Plunges 15.1% - Tale of the Tape
6/23/2014 9:00:00 AM - Zacks.com


Will KaloBios (KBIO) Continue to Surge Higher? - Tale of the Tape
6/13/2014 10:22:23 AM - Zacks.com


KaloBios (KBIO) Worth Watching: Stock Jumps 12.7% - Tale of the Tape
6/11/2014 9:25:00 AM - Zacks.com


Weakness Seen in Relypsa (RLYP): Stock Falls 7.4% - Tale of the Tape
6/11/2014 8:58:00 AM - Zacks.com


Teva to Buy Labrys Biologics - Analyst Blog
6/4/2014 12:10:00 PM - Zacks.com


KaloBios Pharmaceuticals (KBIO) Worth Watching: Stock Up 5.3% - Tale of the Tape
5/29/2014 9:25:00 AM - Zacks.com


KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape
5/12/2014 7:58:19 AM - Zacks.com


KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape
4/3/2014 9:28:01 AM - Zacks.com


KaloBios (KBIO) Crumbles: Stock Falls by 6.3% - Tale of the Tape
2/3/2014 9:46:01 AM - Zacks.com


KaloBios to Stop KB003 Development for Asthma - Analyst Blog
1/30/2014 7:50:01 PM - Zacks.com


KaloBios Pharmaceuticals: Undervalued Company With Huge Potential Catalyst
12/27/2013 11:11:00 AM - Seeking Alpha


Actavis Cuts 350 Sales Positions in the U.S. - Analyst Blog
11/22/2013 12:50:01 PM - Zacks.com


KaloBios Prices Stock Offering - Analyst Blog
9/27/2013 4:33:39 PM - Zacks.com


KaloBios to Raise Funds - Analyst Blog
9/24/2013 4:17:43 PM - Zacks.com


Data on KaloBios' KB001 Published - Analyst Blog
9/20/2013 6:25:01 PM - Zacks.com


KaloBios Loss Wider-than-Expected - Analyst Blog
8/22/2013 2:35:01 PM - Zacks.com


KaloBios: An Undervalued Pharmaceutical Company With Remarkable Pipeline
6/13/2013 2:51:00 PM - Seeking Alpha


KaloBios Pharma Incurs Wider Loss - Analyst Blog
4/3/2013 1:22:08 PM - Zacks.com


KaloBios Pharmaceuticals - A Failed Public Offering Waiting For Good News
2/19/2013 4:33:00 PM - Seeking Alpha